![Qi Feng](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Career history of Qi Feng
Former positions of Qi Feng
Companies | Position | Start | End |
---|---|---|---|
I-MAB | Public Communications Contact | 2020-04-19 | 2024-03-30 |
Amgen KK
![]() Amgen KK Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Amgen KK is a wholly owned Japanese affiliate of Amgen Inc., one of the largest independent biotechnology companies in the world. The company is based in Tokyo, Japan. Amgen KK focuses on disease areas with significant unmet medical needs, including cardiometabolic, oncological, bone, inflammation/immune and neurological diseases. Currently, approximately 600 employees engage in activities from clinical development to sales with the mission of "to serve patients – doing everything we can now, for the patients." The Japanese company was founded by Fuminori Yoshida. Amgen KK was acquired by Takeda Pharmaceutical Co., Ltd. from Amgen, Inc. on March 31, 2008 for $16.58 million. | Corporate Officer/Principal | 2018-02-28 | 2020-02-29 |
Training of Qi Feng
Cornell University | Undergraduate Degree |
Harvard Business School | Masters Business Admin |
Statistics
International
United States | 4 |
Japan | 2 |
Operational
Undergraduate Degree | 1 |
Public Communications Contact | 1 |
Corporate Officer/Principal | 1 |
Sectoral
Consumer Services | 3 |
Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
I-MAB | Health Technology |
Private companies | 1 |
---|---|
Amgen KK
![]() Amgen KK Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Amgen KK is a wholly owned Japanese affiliate of Amgen Inc., one of the largest independent biotechnology companies in the world. The company is based in Tokyo, Japan. Amgen KK focuses on disease areas with significant unmet medical needs, including cardiometabolic, oncological, bone, inflammation/immune and neurological diseases. Currently, approximately 600 employees engage in activities from clinical development to sales with the mission of "to serve patients – doing everything we can now, for the patients." The Japanese company was founded by Fuminori Yoshida. Amgen KK was acquired by Takeda Pharmaceutical Co., Ltd. from Amgen, Inc. on March 31, 2008 for $16.58 million. | Health Technology |
- Stock Market
- Insiders
- Qi Feng
- Experience